RYANODINE (cas 15662-33-6) receptor dysfunction in human disorders☆
-
Add time:09/06/2019 Source:sciencedirect.com
Regulation of intracellular calcium (Ca2+) is critical in all cell types. The RYANODINE (cas 15662-33-6) receptor (RyR), an intracellular Ca2+ release channel located on the sarco/endoplasmic reticulum (SR/ER), releases Ca2+ from intracellular stores to activate critical functions including muscle contraction and neurotransmitter release. Dysfunctional RyR-mediated Ca2+ handling has been implicated in the pathogenesis of inherited and non-inherited conditions including heart failure, cardiac arrhythmias, skeletal myopathies, diabetes, and neurodegenerative diseases. Here we have reviewed the evidence linking human disorders to RyR dysfunction and describe novel approaches to RyR-targeted therapeutics.
We also recommend Trading Suppliers and Manufacturers of RYANODINE (cas 15662-33-6). Pls Click Website Link as below: cas 15662-33-6 suppliers
Prev:Research paperStructural development of a type-1 RYANODINE (cas 15662-33-6) receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay
Next:Basal RYANODINE (cas 15662-33-6) receptor activity suppresses autophagic flux) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Molecules in focusRYANODINE (cas 15662-33-6) receptor Ca2+ release channel post-translational modification: Central player in cardiac and skeletal muscle disease09/10/2019
- A de novo heterozygous cardiac RYANODINE (cas 15662-33-6) receptor gene (RYR2) mutation in a catecholaminergic polymorphic ventricular tachycardia patient09/09/2019
- ArticleMapping RYANODINE (cas 15662-33-6) Binding Sites in the Pore Cavity of RYANODINE (cas 15662-33-6) Receptors09/08/2019
- Basal RYANODINE (cas 15662-33-6) receptor activity suppresses autophagic flux09/07/2019
- Research paperStructural development of a type-1 RYANODINE (cas 15662-33-6) receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay09/05/2019
- Synthesis, insecticidal evaluation and mode of action of novel anthranilic diamide derivatives containing sulfur moiety as potential RYANODINE (cas 15662-33-6) receptor activators09/04/2019
- Interaction of the Homer1 EVH1 domain and skeletal muscle RYANODINE (cas 15662-33-6) receptor09/03/2019
- ArticleInfluence of Lipid Mimetics on Gating of RYANODINE (cas 15662-33-6) Receptor09/02/2019
- A novel target for the promotion of dermal wound healing: RYANODINE (cas 15662-33-6) receptors09/01/2019